{"id":68952,"date":"2026-03-03T07:29:50","date_gmt":"2026-03-03T07:29:50","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68952"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"semax","status":"publish","type":"product","link":"https:\/\/medsbase.com\/it\/product\/semax\/","title":{"rendered":"Semax"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Risposta rapida \u2014 Cos'\u00e8 il Semax?<\/h3>\n<p style=\"margin: 0;\"><strong>Semax<\/strong> is a synthetic heptapeptide based on the 4\u201310 fragment of adrenocorticotropic hormone (ACTH). Developed at the Institute of Molecular Genetics in Russia, it is a nootropic and neuroprotective peptide best known for potent <strong>elevazione del BDNF<\/strong> e <strong>somministrazione intranasale al SNC<\/strong>. Approved in Russia as a stroke-recovery drug \u2014 not FDA-approved. Supplied in 5\u00a0mg to 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Cosa ottieni con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/it\/reviews\/\">recensioni dei clienti<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ogni ordine \u00e8 coperto dalla nostra <a href=\"https:\/\/medsbase.com\/it\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica di Garanzia di Rispedizione<\/strong><\/a> \u2014 se il tuo pacco non arriva entro 20 giorni lavorativi, lo rispediamo.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifiche<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Dettaglio<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Numero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">80714-61-0<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formula Molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>37<\/sub>H<sub>51<\/sub>N<sub>9<\/sub>O<sub>10<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">813.93 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequenza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvere liofilizzata (o come fornito)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Purezza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificato con HPLC, COA disponibile su richiesta)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Conservazione<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizzato: 2\u20138 \u00b0C (frigorifero) per lo stock di lavoro; \u221220 \u00b0C per lo stoccaggio a lungo termine di flaconcini non aperti. Ricostituito: 2\u20138 \u00b0C, utilizzare entro ~30 giorni. Proteggere dalla luce. Non congelare e scongelare la soluzione ricostituita.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e0<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Acqua batteriostatica (consigliata) o acqua sterile per finestre d'uso pi\u00f9 brevi<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Cos'\u00e8 il Semax?<\/h2>\n<p><strong>Semax<\/strong> (Met-Glu-His-Phe-Pro-Gly-Pro, sequence MEHFPGP) is a synthetic seven-amino-acid peptide developed in the 1980s at the Russian Institute of Molecular Genetics by Mekhedov, Malyshev, and collaborators. It is a structural analog of the ACTH 4\u201310 fragment \u2014 the central biologically-active region of adrenocorticotropic hormone \u2014 modified with a C-terminal Pro-Gly-Pro sequence that extends half-life and improves CNS penetration. Semax is <strong>approvato nella Federazione Russa<\/strong> as a prescription medication for acute ischemic stroke and cognitive-disorder indications, sold under the trade names Semax and Semaks. It is not approved by the FDA, EMA, or other Western regulators, so Western users access it through specialist supply. Molecular weight approximately 813.9\u00a0Da. Supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. Semax is <strong>for clinical studies use only<\/strong> outside its approved jurisdiction. For mechanism, clinical history, and context, see our <a href=\"https:\/\/medsbase.com\/it\/semax-peptide-nootropic-guide\/\">Semax guide<\/a>. <\/p>\n<h2>Meccanismo d'azione \u2014 BDNF, Melanocortina e Penetrazione nel SNC<\/h2>\n<p>Semax&#8217;s pharmacology combines three features that make it unusually well-studied for a nootropic peptide:<\/p>\n<ul>\n<li><strong>elevazione del BDNF<\/strong> \u2014 the most consistent observation across the Semax literature is rapid upregulation of <strong>fattore neurotrofico derivato dal cervello (BDNF)<\/strong> nell'ippocampo e nella corteccia. Il BDNF \u00e8 un regolatore principale della plasticit\u00e0 sinaptica, della sopravvivenza neuronale e del consolidamento della memoria a lungo termine; la sua elevazione \u00e8 la base molecolare proposta per gli effetti cognitivi e neuroprotettivi osservati.<\/li>\n<li><strong>Attivit\u00e0 correlata ai recettori della melanocortina<\/strong> \u2014 poich\u00e9 Semax \u00e8 derivato da ACTH 4\u201310, conserva una modesta affinit\u00e0 di legame per MC3R e MC4R. Questa attivit\u00e0 dei recettori della melanocortina \u00e8 distinta dagli effetti periferici legati all'abbronzatura di analoghi pi\u00f9 ampi della MC come <a href=\"https:\/\/medsbase.com\/it\/melanotan-ii\/\">Melanotan II<\/a> perch\u00e9 Semax agisce centralmente e non attiva in modo significativo MC1R.<\/li>\n<li><strong>Somministrazione intranasale nel SNC<\/strong> \u2014 Semax \u00e8 stato specificamente progettato per <strong>naso-cervello<\/strong> administration. Intranasal delivery bypasses the blood-brain barrier via olfactory-epithelial and trigeminal pathways, producing rapid CNS exposure within minutes. This is the primary administration route and is how the approved Russian products are administered.<\/li>\n<\/ul>\n<p>Additional reported mechanisms include attenuation of oxidative stress in neuronal study models, modulation of enkephalin and monoamine pathways, and effects on attention-related dopaminergic signaling \u2014 the combination that underpins ADHD-relevant contexts. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Semax is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Cognitive studies<\/strong> \u2014 memory, attention, and executive-function studies in rodent behavioral models (Dolotov et al., J Neurochem 2006)<\/li>\n<li><strong>Stroke recovery<\/strong> \u2014 modelli di ictus ischemico su roditori; Semax ha approvazione umana in Russia per questa indicazione<\/li>\n<li><strong>ADHD studies<\/strong> \u2014 modelli comportamentali su roditori per attenzione\/iperattivit\u00e0<\/li>\n<li><strong>Neuroprotezione<\/strong> \u2014 oxidative-stress, glutamate toxicity, and neuronal-survival studies in aging models<\/li>\n<li><strong>Mood studies<\/strong> \u2014 anxiety and depression behavioral studies in rodent models<\/li>\n<li><strong>BDNF signaling studies<\/strong> \u2014 Semax is one of the most consistent peptide-based BDNF elevators available for preclinical studies (Kaplan et al., Neurosci Biobehav Rev 2022)<\/li>\n<li><strong>Stacking studies<\/strong> \u2014 spesso abbinato a <a href=\"https:\/\/medsbase.com\/it\/nad\/\">NAD+<\/a> e <a href=\"https:\/\/medsbase.com\/it\/epitalon\/\">Epitalon<\/a> in longevity \/ cognitive protocols<\/li>\n<\/ul>\n<p>Per un contesto pi\u00f9 ampio sui peptidi nootropici e per la longevit\u00e0, consultare il <a href=\"https:\/\/medsbase.com\/it\/peptides\/\">catalogo peptidi<\/a>. <\/p>\n<h2>Concentrazioni e Dosaggi Disponibili<\/h2>\n<p>MedsBase offre Semax nelle seguenti dimensioni di flaconcini liofilizzati:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dosaggio per Flaconcino<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso d'Uso Tipico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dimensioni della Confezione<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pilot dosing, short protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 supports ~33 administrations at 300 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Semax can be administered either intranasally (the primary administration route) or subcutaneously as an SC-reference dosing arm. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>Confronto \u2014 Semax vs altri peptidi cognitivi\/longevit\u00e0<\/h2>\n<p>Semax sits within a small group of nootropic and longevity peptides with published preclinical studies. Each uses a distinct mechanism:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Semax<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epitalon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NAD+<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Meccanismo primario<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aumento del BDNF, correlato al MC<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Segnalazione telomerasica\/pineale<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Coenzima sirtuina\/PARP<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Recupero cognitivo e post-ictus<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Lunghezza dei telomeri, ritmo circadiano<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Energia cellulare, longevit\u00e0<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Via principale<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Intranasale (anche SC)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sottocutaneo<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">SC, IM o IV<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dosaggio tipico<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\u2013600 mcg intranasale al giorno<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201310 mg SC al giorno<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50\u2013100 mg SC\/IM al giorno<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Regolatorio<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Approvato in Russia<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Non approvato<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Non approvato<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Users often study Semax together with <a href=\"https:\/\/medsbase.com\/it\/epitalon\/\">Epitalon<\/a> e <a href=\"https:\/\/medsbase.com\/it\/nad\/\">NAD+<\/a> in longevity \/ neurocognitive-aging protocols because their mechanisms are complementary. <\/p>\n<h2>Conservazione e ricostituzione<\/h2>\n<p><strong>Prima della ricostituzione:<\/strong> conservare i flaconcini liofilizzati refrigerati a 2\u20138 \u00b0C nella confezione originale, stabili fino a 36 mesi. Evitare cicli di congelamento-scongelamento della polvere. <strong>Procedura di ricostituzione:<\/strong> for intranasal studies, reconstitute at a concentration matched to a nasal dropper or spray. For SC-reference dosing, follow the chart above. Swirl gently \u2014 do <strong>not<\/strong> agitare \u2014 e attendere 5\u201310 minuti per la completa dissoluzione. <strong>Dopo la ricostituzione:<\/strong> conservare in frigorifero a 2\u20138\u00a0\u00b0C e utilizzare entro 30 giorni. Non congelare la soluzione ricostituita. <\/p>\n<h2 id=\"faqs\">Domande frequenti<\/h2>\n<h3>What is Semax used for in studies?<\/h3>\n<p>Semax is used in studies investigating cognitive function, memory, attention, stroke recovery, ADHD-relevant pathways, neuroprotection, mood \/ anxiety studies, and BDNF signaling. It is approved in Russia for ischemic-stroke treatment; in the US and EU it is <strong>not<\/strong> FDA\/EMA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>How is Semax administered in studies?<\/h3>\n<p>The primary administration route is <strong>intranasale<\/strong>, corrispondente al formato di somministrazione del prodotto approvato in Russia. La somministrazione naso-cervello bypassa la barriera emato-encefalica attraverso le vie olfattive e produce una rapida esposizione del SNC. Alcuni protocolli utilizzano l'iniezione sottocutanea come via di dosaggio di riferimento. La somministrazione orale non \u00e8 efficace perch\u00e9 Semax viene rapidamente degradato dagli enzimi gastrici. <\/p>\n<h3>What is the typical Semax dose?<\/h3>\n<p>Published preclinical and Russian-approved protocols typically use 250\u2013600\u00a0mcg intranasally, 1\u20133 times daily. Some protocols use SC 100\u2013300\u00a0mcg equivalent. A 10\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 5.0\u00a0mg\/mL \u2014 6 ticks on a U-100 SC syringe delivers 300\u00a0mcg. <\/p>\n<h3>Semax \u00e8 approvato dalla FDA?<\/h3>\n<p>No. Semax \u00e8 approvato nella Federazione Russa per indicazioni di ictus ischemico acuto e disturbi cognitivi, ma non \u00e8 <strong>not<\/strong> been approved by the FDA, EMA, MHRA, or any other Western regulator. <\/p>\n<h3>Cosa fa Semax al BDNF?<\/h3>\n<p>Published studies consistently shows rapid and sustained upregulation of brain-derived neurotrophic factor (BDNF) expression in hippocampus and cortex following Semax administration. BDNF is a master regulator of synaptic plasticity and long-term memory consolidation, and its elevation is the proposed mechanistic basis for the cognitive and neuroprotective studies observations. <\/p>\n<h3>Come dovrebbe essere conservato Semax?<\/h3>\n<p>Flaconcini liofilizzati: refrigerati a 2\u20138\u00a0\u00b0C nella confezione originale, stabili fino a 36 mesi. Soluzione ricostituita: refrigerata a 2\u20138\u00a0\u00b0C, utilizzare entro 30 giorni. Non congelare la soluzione ricostituita. <\/p>\n<h3>How do I reconstitute Semax for intranasal studies?<\/h3>\n<p>For nasal delivery, reconstitute at a concentration matched to your nasal dropper or spray delivery volume. A 10\u00a0mg vial in 2\u00a0mL gives 5\u00a0mg\/mL; a typical 50\u2013100\u00a0mcL nasal spray volume then delivers 250\u2013500\u00a0mcg per administration. Study protocols should target the specific per-spray volume of the delivery device used. <\/p>\n<h3>Can Semax be stacked with other peptides in studies?<\/h3>\n<p>S\u00ec. Semax \u00e8 comunemente associato a <a href=\"https:\/\/medsbase.com\/it\/epitalon\/\">Epitalon<\/a> e <a href=\"https:\/\/medsbase.com\/it\/nad\/\">NAD+<\/a> in longevity and cognitive-aging protocols. The mechanisms are complementary \u2014 BDNF-driven neurotrophic signaling (Semax), telomere \/ circadian (Epitalon), cellular-energy \/ sirtuins (NAD+). <\/p>\n<h3>Quali dosaggi sono disponibili su MedsBase?<\/h3>\n<p>MedsBase offre Semax in fiale liofilizzate da 5 mg e 10 mg. Ogni concentrazione \u00e8 disponibile in confezioni da 10, 20 o 30 fiale. Tutte le fiale sono fornite con una purezza HPLC del 99%+ e un certificato di analisi su richiesta. <\/p>\n<h3>Does Semax cause side reported effects?<\/h3>\n<p>Published preclinical studies and Russian clinical-trial data report a clean safety profile. Minor transient nasal irritation after intranasal administration is the most commonly reported observation. No significant systemic side effects have been identified at standard doses. <\/p>\n<h3>Qual \u00e8 l'emivita di Semax?<\/h3>\n<p>Semax has a short plasma half-life of approximately 2\u20133 minutes when administered intranasally or subcutaneously, attributed to rapid proteolytic degradation. Despite rapid systemic clearance, Semax demonstrates prolonged cognitive effects in preclinical studies \u2014 estimated at 20\u201324 hours \u2014 due to sustained BDNF upregulation in the brain rather than direct receptor occupation. <\/p>\n<h3>How does Semax compare to Selank in studies?<\/h3>\n<p>Semax and Selank are both synthetic nootropic peptides with Russian origins, but with distinct pharmacological profiles. Semax activates the BDNF\/TrkB pathway and shows stronger stimulatory and cognitive-enhancing effects in preclinical studies. Selank is derived from the immunomodulatory peptide tuftsin and has more pronounced anxiolytic properties. Studies stacks sometimes combine both for complementary cognitive and anxiolytic effects. <\/p>\n<h3>Posso ordinare Semax per la spedizione internazionale?<\/h3>\n<p>S\u00ec. MedsBase spedisce Semax in tutto il mondo dalla nostra rete dedicata di spedizione di peptidi. Gli ordini contenenti solo peptidi si qualificano per il nostro servizio di spedizione peptidi autonomo. Gli ordini vengono spediti in imballaggi a temperatura controllata con tracciabilit\u00e0 completa. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/it\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/it\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/it\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Agonista selettivo della grelina \u2014 pulso pulito di GH senza cortisolo\/prolattina<\/li>\n<li><a href=\"\/it\/cjc-1295-with-dac\/\"><strong>CJC-1295 con DAC<\/strong><\/a> \u2014 Analogico GHRH con emivita prolungata<\/li>\n<li><a href=\"\/it\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Approfondimenti<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Leggi la nostra guida completa basata sull'evidenza: <a href=\"https:\/\/medsbase.com\/it\/semax-peptide-nootropic-guide\/\"><strong>Semax \u2014 mechanism, Russian clinical history, and honest studies<\/strong><\/a>. Covers BDNF pharmacology, ACTH 4-10 origin, intranasal delivery protocols, dosing ranges, and comparative nootropic context.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Supporta la resilienza neuronale<br \/>\n\u2705 Potenzia i percorsi cognitivi<br \/>\n\u2705 Modula l'attivit\u00e0 dei neurotrasmettitori<br \/>\n\u2705 Promuove i fattori neurotrofici<br \/>\n\u2705 Stabilizza i marcatori della risposta allo stress<\/p>\n<p><strong>Semax<\/strong> contiene composto peptidico sintetico.<\/p>","protected":false},"featured_media":70979,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5467,5468,5466],"class_list":["post-68952","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-acth-4-7","product_tag-pro-gly-pro","product_tag-semax","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product\/68952","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/comments?post=68952"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media\/70979"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media?parent=68952"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_brand?post=68952"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_cat?post=68952"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_tag?post=68952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}